NCT01254409 A Phase 1b Study of IV PRM151 in Patients With Idiopathic Pulmonary Fibrosis (IPF) Status COMPLETED Phase PHASE1
NCT01254331 An Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local Environment Status COMPLETED Phase PHASE3
NCT01253564 A Study of RO5185426 in Previously Treated Melanoma Patients With Brain Metastases Status COMPLETED Phase PHASE2
NCT01251120 A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis Status TERMINATED Phase PHASE4
NCT01250379 A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA) Status COMPLETED Phase PHASE3
NCT01250119 A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients. Status COMPLETED Phase PHASE2
NCT01249833 Effect of Oseltamivir on Cognitive Function in Subjects With Influenza Status COMPLETED Phase PHASE4
NCT01247324 A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis Status COMPLETED Phase PHASE3
NCT01245634 A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Status COMPLETED Phase PHASE2
NCT01245439 A Study of RoActemra/Actemra (Tocilizumab) in Patients With Moderate to Severe Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01239732 A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer Status COMPLETED Phase PHASE3
NCT01238692 A Phase II Study of Oral Panobinostat (LBH589) and Rituximab to Treat Diffuse Large B Cell Lymphoma (DLBCL) Status COMPLETED Phase PHASE2
NCT01237496 Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253 Status COMPLETED Phase PHASE3
NCT01235585 A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25306) Status COMPLETED Phase PHASE3
NCT01235559 A Study of RO4917838 (Bitopertin) in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (WN25305) Status COMPLETED Phase PHASE3
NCT01235520 A Study of RO4917838 in Patients With Sub-optimally Controlled Symptoms of Schizophrenia (NN25307) Status COMPLETED Phase PHASE3
NCT01235507 A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) (ALABASTER) Status COMPLETED Phase PHASE3
NCT01234779 A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia Status COMPLETED Phase PHASE2